Results 221 to 230 of about 12,087 (255)
Some of the next articles are maybe not open access.
The Journal of Clinical Pharmacology, 2008
The tolerability of dapoxetine, a short‐acting selective serotonin reuptake inhibitor being developed for premature ejaculation, was evaluated when coadministered with tamsulosin. Adult men on a stable dose of tamsulosin were randomized to also receive dapoxetine 30 or 60 mg, or placebo, in a crossover design.
Joseph W. Aquilina +3 more
openaire +3 more sources
The tolerability of dapoxetine, a short‐acting selective serotonin reuptake inhibitor being developed for premature ejaculation, was evaluated when coadministered with tamsulosin. Adult men on a stable dose of tamsulosin were randomized to also receive dapoxetine 30 or 60 mg, or placebo, in a crossover design.
Joseph W. Aquilina +3 more
openaire +3 more sources
New practical synthesis of Tamsulosin
Chirality, 2008AbstractThe medicine called Tamsulosin was produced 25 years ago and since then almost 10 new synthesis route has been known. Each process shows the researchers' workstyle, every year, which mainly differs in the way of separating the enantiomers. The applied reaction steps also reflect the development over the past 25 years and the new synthesis is ...
T. Gizur +6 more
openaire +3 more sources
Is Tamsulosin Linked to Dementia in the Elderly?
Current Urology Reports, 2018Lower urinary tract symptoms (LUTS) result from age-related changes in detrusor function and prostatic growth that are driven by alterations in the ratio of circulating androgens and estrogens. Alpha-adrenergic receptor blockers are commonly used to treat LUTS because they influence urethral tone and intra-urethral pressure.
Jason Frankel +2 more
openaire +2 more sources
Drugs & Aging, 2012 The 5α-reductase inhibitor dutasteride and the α(1)-adrenergic receptor antagonist tamsulosin are available as a fixed-dose combination for use in men with symptomatic benign prostatic hyperplasia (BPH) and an enlarged prostate. Dutasteride 0.5 mg/day plus tamsulosin 0.4 mg/day improved lower urinary tract symptoms (LUTS) to a significantly greater ...
openaire +2 more sources
Lower urinary tract symptoms, 2020
The main objective of this study was to evaluate the efficacy of tamsulosin or mirabegron on ureteral stent‐related symptoms.
A. Yavuz +4 more
semanticscholar +1 more source
The main objective of this study was to evaluate the efficacy of tamsulosin or mirabegron on ureteral stent‐related symptoms.
A. Yavuz +4 more
semanticscholar +1 more source
BJU International, 2020
To compare the efficacy and safety of tamsulosin vs the combination of tamsulosin and tadalafil in male lower urinary tract symptoms (LUTS).
S. Nagasubramanian +7 more
semanticscholar +1 more source
To compare the efficacy and safety of tamsulosin vs the combination of tamsulosin and tadalafil in male lower urinary tract symptoms (LUTS).
S. Nagasubramanian +7 more
semanticscholar +1 more source
European Urology Supplements, 2007
Abstract The present paper discusses the consequences of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) and summarises the available data on the impact of tamsulosin oral controlled absorption system (OCAS) on nocturia.
openaire +2 more sources
Abstract The present paper discusses the consequences of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) and summarises the available data on the impact of tamsulosin oral controlled absorption system (OCAS) on nocturia.
openaire +2 more sources
Intraoperative floppy iris syndrome associated with tamsulosin [PDF]
Journal of Cataract and Refractive Surgery, 2005 To assess the incidence and possible causative factors of a newly recognized syndrome, the intraoperative floppy iris (IFIS).Clinical practices in Los Altos and San Rafael, California, USA.A retrospective chart review of consecutive cataract surgeries performed in a 2-surgeon practice over a 12-month period (706 eyes; 511 patients) was used to assess ...
John R. Campbell, David F. Chang
openaire +3 more sources
Pharmacokinetic profile of tamsulosin OCAS
BJU International, 2006The tamsulosin oral‐controlled absorption system (OCAS®) is a new tablet formulation of the α1‐adrenoceptor (α1‐AR) antagonist tamsulosin, which is used for treating lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
Christopher R. Chapple +1 more
openaire +2 more sources
Tamsulosin: current clinical experience
Urology, 2001During the past decade, our understanding of the epidemiology and natural history of benign prostatic hyperplasia (BPH) has improved considerably. Population-based studies confirm that lower urinary tract symptoms (LUTS) are very common among aging men.
openaire +3 more sources